SMS Pharmaceuticals · NSE: SMSPHARMA · BSE: 532815
Q2 FY20 results · Jul–Sep 2019
SMS Pharmaceuticals reported revenue from operations of ₹117.90 crore and net profit of ₹9.55 crore for Q2 FY20 (Jul–Sep 2019), on a consolidated basis.
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 117.90 | — | — | 117.14 | +0.6% |
| Other income | 0.58 | — | — | 0.65 | −11.0% |
| Total income | 118.48 | — | — | 117.79 | +0.6% |
| Profit before tax | 14.42 | — | — | 15.34 | −6.0% |
| Net profit for the period | 9.55 | — | — | 7.77 | +22.9% |
| EPS, basic (₹) | 1.17 | — | — | 0.92 | +27.2% |
| Net margin (%) | 8.1 | — | 6.6 |
| Item | Q2 FY20 | Q2 FY19 | YoY | Q1 FY20 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 117.90 | 134.84 | −12.6% | 117.14 | +0.6% |
| Other income | 0.58 | 1.49 | −60.9% | 0.65 | −11.0% |
| Total income | 118.48 | 136.33 | −13.1% | 117.79 | +0.6% |
| Profit before tax | 14.42 | 19.04 | −24.3% | 15.34 | −6.0% |
| Net profit for the period | 9.55 | 12.56 | −24.0% | 9.48 | +0.7% |
| EPS, basic (₹) | 1.13 | 1.48 | −23.6% | 1.12 | +0.9% |
| Net margin (%) | 8.1 | 9.3 | 8.1 |
Consolidated
- Filed with BSE
- 18 Nov 2019, 15:15 IST
- Board meeting
- 12 Nov 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 18 Nov 2019, 15:15 IST
- Board meeting
- 12 Nov 2019
- Period
- 01 Jul 2019 to 30 Sep 2019
- Review status
- Unaudited
- Source
- XBRL filing on BSE